Facebook-f X-twitter Linkedin-in Instagram Podcast

Podcasts

Episode 41 | Decoding Perioperative Immunotherapy In NSCLC

This episode is hosted by: Dr Pei Ni Ding, Dr Samantha Bowyer, and Mr Naveed Alam.

Decoding Perioperative Immunotherapy In NSCLC

Episode Summary

In this TOGA podcast, we provide an overview of the recent neoadjuvant, adjuvant, and perioperative IO data, the options and considerations for treatment, and the current reimbursement landscape.

Show Hosts

This episode’s host are:

  • Dr Pei Ni Ding, Medical Oncologist from Westmead and Nepean Hospitals Sydney
  • Dr Samantha Bowyer, Medical Oncologist from Sir Charles Gairdner Hospital in Perth
  • Mr Naveed Alam, Thoracic Surgeon from St Vincents, Epworth and Monash in Melbourne

Show links

Many emerging treatments are discussed in this podcast, and clinicians are reminded that oncology access programs are listed in the medicines access portal. 

Sponsor

This episode is proudly sponsored by MSD. 

 

Play Episode 41 | Decoding Perioperative Immunotherapy In NSCLC

Download Audio File
Listen on Apple
Listen on Spotify

More Podcasts

Headshots of A/Prof Surein Arulananda, A/Prof Mel Moore, Dr. Malinda Itchins. 49 Exploring EGFR Exon 20 Insertion Mutations
49 – Exploring EGFR Exon 20 Insertion Mutations
In this episode of Conversations in Lung Cancer Research, A/Prof Mel Moore, along with thoracic oncologists Dr. Malinda Itchins and A/Prof Surein Arulananda, delve into
Conversations in Lung Cancer Research - Michael Boyer
48 – A Conversation with Prof. Michael Boyer
In this episode of Conversations in Lung Cancer Research, A/Prof Mel Moore interviews Prof Michael Boyer, AM about his extensive career in medical oncology and
Text Conversations in Lung Cancer on Blue background and TOGA logo
47 – Introducing Conversations in Lung Cancer Research
In this introductory episode, A/Prof Mel Moore, announces the evolution of TOGA podcasts to 'Conversations in Lung Cancer Research.'
46 – Navigating Resistance in ALK-Positive NSCLC Patients on TKI Therapy
Dr Rebecca Tay is joined by Professor Ben Solomon and A/Prof Michael Ng to discuss clinical and genetic factors affecting treatment choice for ALK-Positive NSCLC
45 – The Case For IO in Early-Stage NSCLC in a Once in a Lifetime World
Dr Deme Karikios is joined by Dr Lauren Brown and Dr Stephen Barnett to discuss IO in early-stage NSCLC in the Australian context.
44 – LCNEC Challenges in Diagnosis and Treatment
A/Prof Rachel Wong is joined by Dr Patrick Hosking, Dr Mal Itchins, and Dr Sagun Parakh discuss the diagnostic markers when identifying LC-NEC.
Join our community – stay up to date with the latest research, TOGA news and events

The Thoracic Oncology Group of Australasia Limited acknowledges Traditional Owners of Country throughout Australia and recognises the continuing connection to lands, waters and communities. We pay our respect to Aboriginal and Torres Strait cultures; and to Elders past and present.

Contact

PO Box 1103
Thornbury VIC 3071
Ph: +61 3 9087 3550
ABN: 47 641 984 198

Facebook-f X-twitter Linkedin-in Instagram Podcast
TOGA
Quicklinks
TOGA is an ACNC Registered Charity

Thoracic Oncology Group of Australasia is registered with the Australian Taxation Office as an Income Tax Exempt Charitable Entity. Donations $2 and over are tax deductible.

Copyright © 2025 TOGA – Thoracic Oncology Group Australasia. No part of this site may be reproduced without our written permission.